Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Christian Wigley

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2005
Aggresome formationMichael J Corboy, Philip J Thomas, W Christian Wigley
Methods in Molecular Medicine|March 29, 2002
CFTR degradation and aggregationMichael J Corboy, Philip J Thomas, W Christian Wigley
Methods in Molecular Medicine|March 29, 2002
In vitro CFTR folding assaysRhesa D Stidham, W Christian Wigley, Philip J Thomas
International Journal of Molecular Sciences|November 13, 2021
Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACSSuran Nethisinghe, Rosella Abeti, Maheswaran Kesavan, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Assessment of protein folding/solubility in live cellsRhesa D Stidham, W Christian Wigley, John F Hunt, et al.
Plos One|August 25, 2015
Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405Brandon L Probst, Lyndsey McCauley, Isaac Trevino, et al.
BMC Cell Biology|June 2, 2007
Hook2 contributes to aggresome formationGyörgyi Szebenyi, W Christian Wigley, Branden Hall, et al.
Journal of Biomolecular Screening|August 31, 2011
A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1Balajee R Somalinga, Gregory A Miller, Hiba T Malik, et al.
Oxidative Medicine and Cellular Longevity|March 3, 2017
NRF2 as an Emerging Therapeutic TargetIan M Copple, Albena T Dinkova-Kostova, Thomas W Kensler, et al.
Plos One|April 22, 2015
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory ActivityBrandon L Probst, Isaac Trevino, Lyndsey McCauley, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2005
Aggresome formationMichael J Corboy, Philip J Thomas, W Christian Wigley
Methods in Molecular Medicine|March 29, 2002
CFTR degradation and aggregationMichael J Corboy, Philip J Thomas, W Christian Wigley
Methods in Molecular Medicine|March 29, 2002
In vitro CFTR folding assaysRhesa D Stidham, W Christian Wigley, Philip J Thomas
International Journal of Molecular Sciences|November 13, 2021
Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACSSuran Nethisinghe, Rosella Abeti, Maheswaran Kesavan, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Assessment of protein folding/solubility in live cellsRhesa D Stidham, W Christian Wigley, John F Hunt, et al.
Plos One|August 25, 2015
Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405Brandon L Probst, Lyndsey McCauley, Isaac Trevino, et al.
BMC Cell Biology|June 2, 2007
Hook2 contributes to aggresome formationGyörgyi Szebenyi, W Christian Wigley, Branden Hall, et al.
Journal of Biomolecular Screening|August 31, 2011
A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1Balajee R Somalinga, Gregory A Miller, Hiba T Malik, et al.
Oxidative Medicine and Cellular Longevity|March 3, 2017
NRF2 as an Emerging Therapeutic TargetIan M Copple, Albena T Dinkova-Kostova, Thomas W Kensler, et al.
Plos One|April 22, 2015
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory ActivityBrandon L Probst, Isaac Trevino, Lyndsey McCauley, et al.
Pageof 3